Pharmacodynamic monitoring of factor VIII replacement therapy in hemophilia A: Combining thrombin and plasmin generation

BACKGROUND: Clinical severity of hemophilia A (HA) varies, possibly due to interplay of many factors in the hemostatic pathway. Pharmacokinetic monitoring of factor VIII (FVIII) replacement therapy in HA patients consists of measuring FVIII activity levels and subsequent dose adjustment. The Nijmege...

Descripción completa

Detalles Bibliográficos
Autores principales: Valke, Lars L.F.G., Bukkems, Laura H., Barteling, Wideke, Laros‐van Gorkom, Britta A.P., Blijlevens, Nicole M.A., Mathôt, Ron A.A., van Heerde, Waander L., Schols, Saskia E.M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2020
Materias:
HAEMOSTASIS
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7756259/
https://www.ncbi.nlm.nih.gov/pubmed/32979031
http://dx.doi.org/10.1111/jth.15106

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7756259/
https://www.ncbi.nlm.nih.gov/pubmed/32979031
http://dx.doi.org/10.1111/jth.15106

Ejemplares similares